Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,295 results that match your search.22,295 results
  • In Merck & Co Inc v Arrow Pharmaceuticals Limited [2006] FCAFC 91, the Full Federal Court considered Merck's patent for a particular treatment regime using bisphosphonates, which were previously known as inhibitors of bone resorption. Merck had found a particular treatment regime that had a markedly reduced probability of deleterious side effects.
  • About two years ago, a Board of Appeal (BoA) of the European Patent Office (EPO) issued a decision in examination appeal on the patentability of a cosmetic treatment method (T383/03). Recently, it appeared that this decision was "not in line with current well-established practice". The decision itself, but also the fate of the patent and its family members, is an interesting learning case of how things may (not) work in Europe.
  • The difficulties likely to be faced by businesses that seek trade mark protection for three-dimensional signs which have a functional feature were revisited in a recent Opinion of Advocate General Leger in the European Court of Justice (ECJ) in Dyson Ltd v Registrar (Case C-321/03).
  • The Enforcement Directive has changed the way The Netherlands is dealing with legal costs in IP litigation. Willem Leppink of Simmons & Simmons highlights issues for rights owners
  • Caroline Pallard and Dorothea Mayer of Nederlandsch Octrooibureau assess the implications of recent developments in European biotech case law
  • The newly instituted Benelux IP Office now has responsibility for trade mark and design registration in the three countries - and its responsibilities could soon extend even further, as deputy director Dick Verschure tells MIP
  • More and more IP owners are heading to the Chinese courts to enforce their rights. But complex rules on evidence and procedure can quickly entangle plaintiffs and their lawyers. Judy Chan and Ross Parsonage explain how to ensure your IP portfolio is litigation-ready
  • A new index measures the strength of IP protection for the IT industry in 10 key markets. Meir Perez Pugatch explains how the index was compiled, and discusses some of the findings
  • Most companies need to use software or web-based services for searching and watching for third party rights, registering domain names and renewing patents and trade marks. In the first of an annual feature, MIP compares some market-leading products
  • The ECJ has failed to clear confusion over the Dutch approach to cross-border patent litigation. By Peter Hendrick and Bas Berghuis van Woortman of Freshfields Bruckhaus Deringer